Clinical trial

Preeclamptic Patients and Pentraxin 3 & Lipoprotein-associated Phospholipase A2

NCT04239352

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2020-01-20

PhaseN/A

Study timeline

Study start (actual)2020-01-20Date precision: day

Registry last updated2020-05-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pre-Eclampsiaunresolved

Interventions

Pentraxin 3 ; new biomarkerDIAGNOSTIC_TEST

Lipoprotein-associated phospholipase A2 ; new biomarkerDIAGNOSTIC_TEST

Sponsors & collaborators

Kanuni Sultan Suleyman Training and Research Hospitallead sponsor

Mapped research locations

IstanbulTurkey (Türkiye)1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04239352 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.